Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recent updates highlight the advocacy for optimal care for Parkinson's disease patients, including a video featuring a nurse practitioner's insights, while content related to follicular lymphoma treatment options has been removed.
    Difference
    35%
    Check dated 2024-12-21T20:19:52.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    AbbVie has made significant announcements, including the acquisition of Nimble Therapeutics to enhance its immunology pipeline and the completion of the acquisition of Aliada Therapeutics, alongside positive clinical trial results for Epcoritamab and Tavapadon.
    Difference
    100%
    Check dated 2024-12-14T12:20:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    AbbVie is set to present new data on relapsed/refractory multiple myeloma and migraine research focused on women's health at the upcoming Citi's 2024 Global Healthcare Conference and ASH annual meeting, highlighting their commitment to advancing understanding in these areas.
    Difference
    66%
    Check dated 2024-12-07T10:26:43.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Recent updates include AbbVie's European Commission approval of ELAHERE® for treating platinum-resistant ovarian cancer and Allergan Aesthetics offering free online business education courses, while several previous announcements and updates have been removed.
    Difference
    81%
    Check dated 2024-11-23T04:22:44.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    AbbVie has recently awarded 20 individuals living with migraine to support their career aspirations and provided an update on the Phase 2 results for Emraclidine in schizophrenia, which did not meet its primary endpoint but was well-tolerated.
    Difference
    59%
    Check dated 2024-11-15T22:58:37.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has added news alerts for email subscribers, highlighted the upcoming BOTOX® Cosmetic Day on November 07, 2024, and announced a partnership to develop novel cancer therapies, while removing recent news about SkinSpirit's support for Girls Inc. and the nationwide availability of JUVÉDERM® VOLUMA® XC.
    Difference
    55%
    Check dated 2024-11-08T18:05:14.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.